XENE icon

Xenon Pharmaceuticals
XENE

Overview Fund Activity

129 hedge funds and large institutions have $1.44B invested in Xenon Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 50 increasing their positions, 27 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
+11
Holders Change %
+9.32%
% of All Funds
1.99%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.08%
New
37
Increased
50
Reduced
27
Closed
24
Calls
$6.15M
Puts
$4.71M
Net Calls
+$1.44M
Net Calls Change
-$6.62M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$93.5M
2
BI
2
BVF Inc
California
$103M
3
DCM
3
Driehaus Capital Management
Illinois
$97.6M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$56.1M
5
ACA
5
Avoro Capital Advisors
New York
$156M

Top Sellers

1
GTC
1
Ghost Tree Capital
New York
$3.12M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$20.8M
3
NMC
3
NEA Management Company
Maryland
$0
4
SCM
4
Suvretta Capital Management
New York
$21.6M
5
BC
5
Boxer Capital
California
$18.7M
Name Holding Trade Value Shares
Change 		Shares
Change %
PCM
151
Penserra Capital Management
California
– -$14K -940 Closed
CHA
152
Carmichael Hill & Associates
Maryland
– -$1K -80 Closed
3 4 5 6
7